On the basis of these initial results, we examined the relationship between ALKBH3 expression and selected clinicopathological parameters in 132 surgical specimens of NSCLC, comprised of 86 human lung adenocarcinomas and 46 squamous cell carcinomas, in more detail (Table 1). Here, ALKBH3 is linked to lung adenocarcinoma.